1
|
Turel O, Romashkin A, Morrison KM. A model linking video gaming, sleep quality, sweet drinks consumption and obesity among children and youth. Clin Obes 2017; 7:191-198. [PMID: 28320073 DOI: 10.1111/cob.12191] [Citation(s) in RCA: 35] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/02/2017] [Revised: 02/07/2017] [Accepted: 02/19/2017] [Indexed: 12/30/2022]
Abstract
There is a growing need to curb paediatric obesity. The aim of this study is to untangle associations between video-game-use attributes and obesity as a first step towards identifying and examining possible interventions. Cross-sectional time-lagged cohort study was employed using parent-child surveys (t1) and objective physical activity and physiological measures (t2) from 125 children/adolescents (mean age = 13.06, 9-17-year-olds) who play video games, recruited from two clinics at a Canadian academic children's hospital. Structural equation modelling and analysis of covariance were employed for inference. The results of the study are as follows: (i) self-reported video-game play duration in the 4-h window before bedtime is related to greater abdominal adiposity (waist-to-height ratio) and this association may be mediated through reduced sleep quality (measured with the Pittsburgh Sleep Quality Index); and (ii) self-reported average video-game session duration is associated with greater abdominal adiposity and this association may be mediated through higher self-reported sweet drinks consumption while playing video games and reduced sleep quality. Video-game play duration in the 4-h window before bedtime, typical video-game session duration, sweet drinks consumption while playing video games and poor sleep quality have aversive associations with abdominal adiposity. Paediatricians and researchers should further explore how these factors can be altered through behavioural or pharmacological interventions as a means to reduce paediatric obesity.
Collapse
Affiliation(s)
- O Turel
- Department of Information Systems and Decision Sciences, California State University, Fullerton, Fullerton, CA, USA
- Brain and Creativity Institute, Department of Psychology, University of Southern California, Los Angeles, CA, USA
| | - A Romashkin
- Department of Pediatrics, McMaster Children Hospital and Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada
- School of Medicine, University of Queensland, Brisbane, Queensland, Australia
| | - K M Morrison
- Department of Pediatrics, McMaster Children Hospital and Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada
| |
Collapse
|
2
|
Dinleyici E, Kara A, Dalgic N, Kurugol Z, Arica V, Metin O, Temur E, Turel O, Guven S, Yasa O, Bulut S, Tanir G, Yazar A, Karbuz A, Sancar M, Erguven M, Akca G, Eren M, Ozen M, Vandenplas Y. Saccharomyces boulardii CNCM I-745 reduces the duration of diarrhoea, length of emergency care and hospital stay in children with acute diarrhoea. Benef Microbes 2015; 6:415-21. [DOI: 10.3920/bm2014.0086] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Abstract
Evidence from the literature has shown that Saccharomyces boulardii provides a clinically significant benefit in the treatment of acute infectious diarrhoea in children. In this multicentre, randomised, prospective, controlled, single blind clinical trial performed in children with acute watery diarrhoea, we aimed to evaluate the impact of S. boulardii CNCM I-745 in hospitalised children, in children requiring emergency care unit (ECU) stay and in outpatient settings. The primary endpoint was the duration of diarrhoea (in hours). Secondary outcome measures were duration of hospitalisation and diarrhoea at the 3rd day of intervention. In the whole study group (363 children), the duration of diarrhoea was approximately 24 h shorter in the S. boulardii group (75.4±33.1 vs 99.8±32.5 h, P<0.001). The effect of S. boulardii (diarrhoea-free children) was observed starting at 48 h. After 72 h, only 27.3% of the children receiving probiotic still had watery diarrhoea, in contrast to 48.5% in the control group (P<0.001). The duration of diarrhoea was significantly reduced in the probiotic group in hospital, ECU and outpatient settings (P<0.001, P<0.01 and P<0.001, respectively). The percentage of diarrhoea-free children was significantly larger after 48 and 72 h in all settings. The mean length of hospital stay was shorter with more than 36 h difference in the S. boulardii group (4.60±1.72 vs 6.12±1.71 days, P<0.001). The mean length of ECU stay was shorter with more than 19 h difference in the probiotic group (1.20±0.4 vs 2.0±0.3 days, P<0.001). No adverse effects related to the probiotic were noted. Because treatment can shorten the duration of diarrhoea and reduce the length of ECU and hospital stay, there is likely a social and economic benefit of S. boulardii CNCM I-745 in adjunction to oral rehydration solution in acute infectious gastroenteritis in children.
Collapse
Affiliation(s)
- E.C. Dinleyici
- Eskisehir Osmangazi University Faculty of Medicine, Department of Pediatrics, Pediatric Intensive Care and Infectious Disease Unit, 26480 Eskisehir, Turkey
| | - A. Kara
- Hacettepe University Faculty of Medicine, Pediatric Infectious Disease Unit, 06100 Sıhhiye, Ankara, Turkey
| | - N. Dalgic
- Sisli Etfal Training and Research Hospital, Division of Pediatric Infectious Diseases, Halaskargazi St., 34371 Sisli, Istanbul, Turkey
| | - Z. Kurugol
- Ege University Faculty of Medicine, Department of Pediatrics, Bornova, 35100 Izmir, Turkey
| | - V. Arica
- Okmeydani Education and Research Hospital, Department of Pediatrics, Darulaceze St. 27, 34384 Istanbul, Turkey
| | - O. Metin
- Dr. Sami Ulus Research and Training Hospital of Women’s and Children’s Health and Diseases, Pediatric Infectious Disease Unit, Altindag, 06090 Ankara, Turkey
| | - E. Temur
- Balikligol State Hospital, 63050 Sanliurfa, Turkey
| | - O. Turel
- Department of Pediatric Infectious Disease Unit, Bezmialem Vakif University, Faculty of Medicine, Vatan St., 34093 Istanbul
| | - S. Guven
- Umraniye Education & Research Hospital, Department of Pediatrics, Adem Yavuz St. 1, Istanbul, Turkey
| | - O. Yasa
- Department of Pediatrics, Goztepe Training and Research Hospital, SB Istanbul Medeniyet University, Dr. Erkin St., Istanbul, Turkey
| | - S. Bulut
- Ege University Faculty of Medicine, Department of Pediatrics, Bornova, 35100 Izmir, Turkey
| | - G. Tanir
- Dr. Sami Ulus Research and Training Hospital of Women’s and Children’s Health and Diseases, Pediatric Infectious Disease Unit, Altindag, 06090 Ankara, Turkey
| | - A.S. Yazar
- Umraniye Education & Research Hospital, Department of Pediatrics, Adem Yavuz St. 1, Istanbul, Turkey
| | - A. Karbuz
- Okmeydani Education and Research Hospital, Department of Pediatrics, Darulaceze St. 27, 34384 Istanbul, Turkey
| | - M. Sancar
- Marmara University Faculty of Pharmacy, Clinical Pharmacy Department, Tıbbiye St. 49, 34688 Haydarpasa, Istanbul
| | - M. Erguven
- Department of Pediatrics, Goztepe Training and Research Hospital, SB Istanbul Medeniyet University, Dr. Erkin St., Istanbul, Turkey
| | - G. Akca
- Sisli Etfal Training and Research Hospital, Division of Pediatric Infectious Diseases, Halaskargazi St., 34371 Sisli, Istanbul, Turkey
| | - M. Eren
- Eskisehir Osmangazi University Faculty of Medicine, Department of Pediatrics Gastroenterology and Hepatology, 26480 Eskisehir, Turkey
| | - M. Ozen
- Faculty of Medicine, Department of Pediatrics, Acibadem University, Halkali, 34303, Istanbul
| | - Y. Vandenplas
- Department of Paediatrics, UZ Brussel, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium
| |
Collapse
|